Related Experiment Videos
Use of mini-microaggregated albumin to study reticuloendothelial system (RES) function in C. parvum-treated animals
Abstract:
Mini-microaggregated albumin colloid (particle size less than 80 A) and microaggregated albumin colloid (particle size 500-1000 A) made from human serum albumin were conjugated with 99mtechnetium and used to study reticuloendothelial system (RES) function in animals treated intravenously with C. parvum. The uptake in blood, liver and spleen were studied in untreated mice and in mice at various times after treatment with 150 or 300 micrograms of C. parvum. The blood clearance of these materials was studied in rabbits before and at various times after treatment with 0.5 mg/kg of C. parvum. In mice, 80 A-microaggregated albumin was cleared significantly faster from the blood and localized to a greater extent in the liver and spleen after C. parvum treatment. There was a positive correlation between the increased organ weight induced by C. parvum and the accelerated clearance of 80 A-microaggregated albumin. The 80 A-microaggregated albumin was also cleared more rapidly from the blood of rabbits after C. parvum treatment. These studies suggest that 80 A-microaggregated albumin labeled with 99mTc is a useful tool for study of RES function in animals and because of its relatively long t 1/2 may also be useful for studies of human RES function.
Insights
Technetium-99m labeled 80 A microaggregated albumin effectively studies reticuloendothelial system (RES) function. This tracer shows accelerated blood clearance and increased organ uptake after C. parvum treatment in animal models.
Area of Science:
- Nuclear medicine
- Immunology
- Pharmacology
Background:
- The reticuloendothelial system (RES) plays a crucial role in immune responses and clearance of foreign particles.
- Assessing RES function is vital for understanding host defense mechanisms and disease states.
- Previous methods for RES evaluation have limitations in sensitivity and applicability.
Purpose of the Study:
- To evaluate the utility of mini-microaggregated albumin colloid labeled with technetium-99m (99mTc) for studying RES function.
- To investigate the impact of Corynebacterium parvum (C. parvum) administration on RES activity using this novel tracer.
- To compare the performance of different particle sizes of albumin colloid in assessing RES function.
Main Methods:
- Preparation of 99mTc-labeled mini-microaggregated albumin colloid (80 A) and microaggregated albumin colloid (500-1000 A) from human serum albumin.
- Intravenous administration of C. parvum to mice and rabbits to modulate RES activity.
- Measurement of blood clearance and organ (liver, spleen) uptake of the radiolabeled tracers in treated and untreated animals.
- Correlation analysis between organ weight changes and tracer clearance rates.
Main Results:
- In mice, 80 A microaggregated albumin showed significantly faster blood clearance and greater localization in the liver and spleen following C. parvum treatment.
- A positive correlation was observed between C. parvum-induced organ weight increase and accelerated clearance of 80 A microaggregated albumin.
- Rabbits also exhibited more rapid blood clearance of 80 A microaggregated albumin after C. parvum administration.
- The 500-1000 A microaggregated albumin showed different clearance kinetics (data not shown in abstract).
Conclusions:
- 99mTc-labeled 80 A microaggregated albumin is a valuable tool for assessing RES function in animal models.
- The tracer's properties suggest potential utility for studying human RES function due to its relatively long half-life.
- C. parvum treatment significantly enhances RES activity, as effectively demonstrated by this radiolabeled albumin colloid.